Sonnet BioTherapeutics Holdings Inc. (SONN)
Sonnet Releases Virtual Investor "What This Means" Segment
Sonnet Releases Virtual Investor "What This Means" Segment
Artelo Biosciences Receives Notice of Allowance from European Patent Office for the Patent Claims for the Intended Commercial Formulation of ART27.13
BioCardia Reports Second Quarter 2025 Business Highlights and Financial Results
New Form 8-K - Entero Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001104659-25-075970 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item …
FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy
Windtree Announces Istaroxime has been Chosen for a Plenary Session Presentation at the Heart Failure Society of America 2025
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
XOMA Royalty Announces Closing of Tender Offer for Turnstone Biologics
Oragenics Q2 2025 Shareholder Update
Neogen® Establishes Relationship with Biomatter